secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001493152-24-023947
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma shareholders approve 3M-share increase and evergreen provision in equity plan
--------------------------------------------------------------------------------

- Shareholders approved increasing omnibus equity plan shares by 3,000,000 to 4,934,561 total.
- Evergreen provision adopted: automatic annual increase of 5% of outstanding shares on Jan 1 for 10 years from 2025.
- All eight director nominees elected; ratification of KMJ Corbin & Company LLP as auditor passed.
- Meeting had 70.4% of shares present, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/0001493152-24-023947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer